Seres announced its May sales figures, reporting 36,480 vehicles sold, a 17.38% decrease year-over-year. However, year-to-date sales reached 160,386 units, marking an 8.18% increase. The report also noted that a subsidiary of its affiliate, Livzon Pharmaceutical Group, received drug registration approval for a recombinant human follicle-stimulating hormone injection. AI
RANK_REASON This is a standard sales report from a company, not a new product release or significant industry event.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →